Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2019031902) PHARMACEUTICAL COMPOSITION CONTAINING (R)-N-[1-(3,5-DIFLUORO-4-METHANSULFONYLAMINO-PHENYL)-ETHYL]-3-(2-PROPYL-6-TRIFLUOROMETHYL-PYRIDIN-3-YL)-ACRYLAMIDE
Latest bibliographic data on file with the International BureauSubmit observation

Pub. No.: WO/2019/031902 International Application No.: PCT/KR2018/009151
Publication Date: 14.02.2019 International Filing Date: 10.08.2018
IPC:
A61K 9/00 (2006.01) ,A61K 47/38 (2006.01) ,A61K 31/44 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
30
Macromolecular compounds
36
Polysaccharides; Derivatives thereof
38
Cellulose; Derivatives thereof
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
435
having six-membered rings with one nitrogen as the only ring hetero atom
44
Non-condensed pyridines; Hydrogenated derivatives thereof
Applicants:
(주)아모레퍼시픽 AMOREPACIFIC CORPORATION [KR/KR]; 서울시 용산구 한강대로 100 100, Hangang-daero, Yongsan-gu, Seoul 04386, KR
Inventors:
최준호 CHOI, Joon Ho; KR
조원경 CHO, Won Kyung; KR
신광현 SHIN, Kwang-Hyun; KR
우병영 WOO, Byoung Young; KR
이기화 LEE, Ki-Wha; KR
김민수 KIM, Min-Soo; KR
노종화 ROH, Jong Hwa; KR
박미영 PARK, Mi Young; KR
박영호 PARK, Young-Ho; KR
박은실 PARK, Eun Sil; KR
박제홍 PARK, Jae Hong; KR
Agent:
김성호 KIM, Sung Ho; KR
박형달 PARK, Hyung-Dal; KR
Priority Data:
10-2017-010231611.08.2017KR
Title (EN) PHARMACEUTICAL COMPOSITION CONTAINING (R)-N-[1-(3,5-DIFLUORO-4-METHANSULFONYLAMINO-PHENYL)-ETHYL]-3-(2-PROPYL-6-TRIFLUOROMETHYL-PYRIDIN-3-YL)-ACRYLAMIDE
(FR) COMPOSITION PHARMACEUTIQUE CONTENANT UN (R)-N-[1-(3,5-DIFLUORO-4-MÉTHANESULFONYLAMINO-PHÉNYL)-ÉTHYL]-3-(2-PROPYL-6-TRIFLUOROMÉTHYL-PYRIDIN-3-YL)-ACRYLAMIDE
(KO) (R)-N-[1-(3,5-다이플루오로-4-메테인설폰일아미노-페닐)-에틸]-3-(2-프로필-6-트라이플루오로메틸-피리딘-3-일)-아크릴아마이드를 함유하는 약학 조성물
Abstract:
(EN) The present invention relates to a pharmaceutical composition which comprises (R)-N-[1-(3,5-difluoro-4-methansulfonylamino-phenyl)-ethyl]-3-(2-propyl-6-trifluoromethyl-pyridin-3-yl)-acrylamide as a first component and a cellulosic polymer as a second component, wherein the composition of the present invention has a formulation characteristic in which crystal formation is delayed for a long time.
(FR) La présente invention concerne une composition pharmaceutique qui comprend un (R)-N-[1-(3,5-difluoro-4-méthanesulfonylamino-phényl)-éthyl]-3-(2-propyl-6-trifluorométhyl-pyridin-3-yl)-acrylamide à titre de premier composant et un polymère cellulosique à titre de second composant, où la composition selon la présente invention a une caractéristique de formulation dans laquelle la formation de cristaux est retardée pendant longtemps.
(KO) (R)-N-[1-(3,5-다이플루오로-4-메테인설폰일아미노-페닐)-에틸]-3-(2-프로필-6-트라이플루오로메틸-피리딘-3-일)-아크릴아마이드를 제1 성분으로 포함하고, 셀룰로오스계 폴리머를 제2 성분으로 포함하는 약학 조성물에 관한 것으로, 본 발명의 조성물은 결정형성이 장기간 지연되는 제형 특성을 가진다.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: Korean (KO)
Filing Language: Korean (KO)